OPKOPKO Health, Inc.

$933M

Q3 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$174M-2.8% YoY

Gross Profit

$40M23.1% margin

Operating Income

$14M8.2% margin

Net Income

$25M14.3% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

-4.7%

Cash Flow

Operating Cash Flow

-$77M

Free Cash Flow

-$85M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$853M

Stockholders' Equity

$1.4B

Cash & Equivalents

$406M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$174M	$179M	-2.8%
Gross Profit	$40M	$48M	-15.8%
Operating Income	$14M	-$64M	+122.1%
Net Income	$25M	-$84M	+129.5%

Revenue Segments

Service

$121M70%

Product

$39M23%

Transfer of Intellectual Property and Other

$13M8%

Geographic Segments

UNITED STATES

$133M76%

CHILE

$17M10%

IRELAND

$12M7%

SPAIN

$6M4%

MEXICO

$6M3%

Other Countries

$756,0000%

ISRAEL

$196,0000%

OPK Q3 2024 Earnings — OPKO Health, Inc. Revenue & Financial Results | Market Cap Arena